UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Engineering a humanized animal model of polycythemia vera with minimal JAK2V617F mutant allelic burden

Haematologica (Roma), 2024-03, Vol.109 (3), p.968-973

2024

Volltextzugriff (PDF)

Author Response

Indian journal of critical care medicine, 2023-12, Vol.27 (12), p.945-946

Krishnan, Aishwarya

2023

Volltextzugriff (PDF)

Morphological variations of the condylar head among children aged 4-15 years: A panoramic study

Journal of the Indian Society of Pedodontics and Preventive Dentistry, 2021-10, Vol.39 (4), p.353-357

2021

Volltextzugriff (PDF)

Evaluating the mucolytic effectiveness of Ambroxol and N-Acetylcysteine in patients with Acute exacerbation of chronic obstructive pulmonary disease

Clinical epidemiology and global health, 2024-11, Vol.30, p.101789, Article 101789

2024

Volltextzugriff (PDF)

675 Goal setting by adolescents with cerebral palsy – a qualitative service review

Archives of disease in childhood, 2022-08, Vol.107 (Suppl 2), p.A233-A234

2022

Volltextzugriff (PDF)

Using a Humanized Animal Model to Determine the Minimum JAK2V617F Mutant Allele Burden Required to Generate MPN Pathologies

Blood, 2022-11, Vol.140, p.6744-6745

2022

Volltextzugriff (PDF)

Using a Humanized Animal Model to Determine the Minimum JAK2 V617F Mutant Allele Burden Required to Generate MPN Pathologies

Blood, 2022-11, Vol.140 (Supplement 1), p.6744-6745

2022

Volltextzugriff (PDF)

Mutational Profile of Children with Myeloproliferative Neoplasms

Blood, 2022-11, Vol.140 (Supplement 1), p.3991-3992

2022

Volltextzugriff (PDF)

3056 – DNMT3A MUTATIONS UPREGULATE CELL ADHESION MOLECULES TO PROMOTE INVASIVENESS OF T-ALL CELLS

Experimental hematology, 2023, Vol.124, p.S78

2023

Volltextzugriff (PDF)

Abstract P073: Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis

Cancer prevention research (Philadelphia, Pa.), 2023-01, Vol.16 (1_Supplement), p.P073-P073

2023

Volltextzugriff (PDF)

Transcriptome Profiling of Pediatric Myeloproliferative Neoplasms Demonstrates Dysregulation of Platelet-Relevant Genes and Enrichment of Inflammatory and JAK2 Mediated Complement Pathways

Blood, 2019-11, Vol.134 (Supplement_1), p.4203-4203

2019

Volltextzugriff (PDF)

EPAC Regulates Melanoma Growth by Stimulating mTORC1 Signaling and Loss of EPAC Signaling Dependence Correlates with Melanoma Progression

Molecular cancer research, 2022-10, Vol.20 (10), p.1548-1560

2022

Volltextzugriff (PDF)

The BMP/SMAD Pathway Is a Key Mediator of Leukemic Transformation of TP53-Mutant Post-MPN AML

Blood, 2021-11, Vol.138 (Supplement 1), p.626-626

2021

Volltextzugriff (PDF)

The Efficacy of Vision, Aphasia, Neglect Assessment in Predicting Emergent Large Vessel Occlusion in Patients Presenting with a Cerebrovascular Accident to the Emergency Department

Indian journal of critical care medicine, 2023-07, Vol.27 (7), p.475-481

2023

Volltextzugriff (PDF)

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation

Blood, 2022-06, Vol.139 (25), p.3630-3646

2022

Volltextzugriff (PDF)

Abstract 3548: EPAC-RAP1, the alternative cyclic AMP signaling pathway, regulates cell cycle progression in primary melanoma cells

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3548-3548

2018

Volltextzugriff (PDF)

LSD1 Inhibitor CPI-482 Shows Efficacy and Prolongs Survival in Mouse Models of AML and Post-MPN AML in the Context of Constitutive JAK-STAT Pathway Activation

Blood, 2020-11, Vol.136 (Supplement 1), p.50-51

2020

Volltextzugriff (PDF)

3225 – DNA METHYLATION-INDEPENDENT FUNCTIONS OF DNMT3A REGULATE HEMATOPOIETIC STEM CELL FUNCTION

Experimental hematology, 2023, Vol.124, p.S162

2023

Volltextzugriff (PDF)

3168 – TARGETING JAK1 SIGNALING FOR MOLECULAR PREVENTION IN CLONAL HEMATOPOIESIS

Experimental hematology, 2023, Vol.124, p.S133

2023

Volltextzugriff (PDF)

Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms

Clinical cancer research, 2021-06, Vol.27 (12), p.3456-3468

2021

Volltextzugriff (PDF)

KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress

Leukemia, 2023-04, Vol.37 (4), p.728-740

2023

Volltextzugriff (PDF)

Evaluation of Tagraxofusp (SL-401) Alone and in Combination with Ruxolitinib for the Treatment of Myeloproliferative Neoplasms

Blood, 2019-11, Vol.134 (Supplement_1), p.2967-2967

2019

Volltextzugriff (PDF)

Increased Interleukin-8 (IL8)-CXCR2 Signaling Promotes Progression of Bone Marrow Fibrosis in Myeloproliferative Neoplasms

Blood, 2020-11, Vol.136 (Supplement 1), p.6-7

2020

Volltextzugriff (PDF)

Engineering a humanized animal model of polycythemia vera with minimal JAK2 V617F mutant allelic burden

Haematologica (Roma), 2024-03, Vol.109 (3), p.968

2024

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(35)
Humans
(12)
Animals
(11)
Hematology
(8)
Biochemistry & Molecular Biology
(7)
Signal Transduction
(6)
Mice
(5)
Microscopy
(5)
Biology
(4)
Cardiovascular Diseases
(4)
General & Internal Medicine
(4)
Mutation
(4)
Myeloproliferative Disorders - Genetics
(4)
Original
(4)
Pharmacology & Pharmacy
(4)
Proteins
(4)
Technology
(4)
Age
(3)
Alcoholics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Engineering a humanized animal model of polycythemia vera with minimal JAK2V617F mutant allelic burden

Author Response

Morphological variations of the condylar head among children aged 4-15 years: A panoramic study

Evaluating the mucolytic effectiveness of Ambroxol and N-Acetylcysteine in patients with Acute exacerbation of chronic obstructive pulmonary disease

675 Goal setting by adolescents with cerebral palsy – a qualitative service review

Using a Humanized Animal Model to Determine the Minimum JAK2V617F Mutant Allele Burden Required to Generate MPN Pathologies

Using a Humanized Animal Model to Determine the Minimum JAK2 V617F Mutant Allele Burden Required to Generate MPN Pathologies

Mutational Profile of Children with Myeloproliferative Neoplasms

3056 – DNMT3A MUTATIONS UPREGULATE CELL ADHESION MOLECULES TO PROMOTE INVASIVENESS OF T-ALL CELLS

Abstract P073: Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis

Transcriptome Profiling of Pediatric Myeloproliferative Neoplasms Demonstrates Dysregulation of Platelet-Relevant Genes and Enrichment of Inflammatory and JAK2 Mediated Complement Pathways

EPAC Regulates Melanoma Growth by Stimulating mTORC1 Signaling and Loss of EPAC Signaling Dependence Correlates with Melanoma Progression

The BMP/SMAD Pathway Is a Key Mediator of Leukemic Transformation of TP53-Mutant Post-MPN AML

The Efficacy of Vision, Aphasia, Neglect Assessment in Predicting Emergent Large Vessel Occlusion in Patients Presenting with a Cerebrovascular Accident to the Emergency Department

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation

Abstract 3548: EPAC-RAP1, the alternative cyclic AMP signaling pathway, regulates cell cycle progression in primary melanoma cells

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis

LSD1 Inhibitor CPI-482 Shows Efficacy and Prolongs Survival in Mouse Models of AML and Post-MPN AML in the Context of Constitutive JAK-STAT Pathway Activation

3225 – DNA METHYLATION-INDEPENDENT FUNCTIONS OF DNMT3A REGULATE HEMATOPOIETIC STEM CELL FUNCTION

3168 – TARGETING JAK1 SIGNALING FOR MOLECULAR PREVENTION IN CLONAL HEMATOPOIESIS

Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms

KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress

Evaluation of Tagraxofusp (SL-401) Alone and in Combination with Ruxolitinib for the Treatment of Myeloproliferative Neoplasms

Increased Interleukin-8 (IL8)-CXCR2 Signaling Promotes Progression of Bone Marrow Fibrosis in Myeloproliferative Neoplasms

Engineering a humanized animal model of polycythemia vera with minimal JAK2 V617F mutant allelic burden

Suchergebnisse filtern